Ascertaining the acceptability of healthcare provision to service users is an important factor in promoting service uptake, especially for populations who are reluctant to access care.
Application of a Discrete Choice Experiment Approach to Support the Design of a Hepatitis C Testing Service in Primary Care

Introduction
The World Health Organisation Guidelines on Testing for Hepatitis B and C establish critical enablers for the provision of efficient and effective services. Suggested best practice includes implementation of simplified, decentralised care pathways, with task-shifting to nonspecialised staff (WHO 2017) . Additionally such services should be delivered in a way that is acceptable to service users, especially for populations who are reluctant to access care. It is important also to consider testing as part of the continuum of care to HCV cure rather than an isolated step (WHO 2016).
In developed countries, people who inject drugs (PWIDs) are the major group affected by hepatitis C (HCV) infection (WHO 2016) . In communities where heroin is the principle drug injected research suggests that around 40% of people prescribed Opioid Substitution Therapy (OST) are infected (Aspinall, Doyle, Corson, Hellard, Hunt, Goldberg...Hutchinson 2015; Edlin, Kresina, Raymond, Carden, Gourevitch, Cheever, Cargill 2005). In current HCV testing and treatment pathways within the United Kingdom, less than 10% of the OST population are tested for HCV and a similar pattern is seen across the world: a depressing repetition of waterfall plots shows people with HCV infection are lost to care at each step (Iveson, Grebely, Catlett, Cunnigham, Dore, Maher 2017).
The barriers that prevent uptake of HCV testing and treatment have been characterised as system-level, practitioner-level and patient level (Grebely, Oser, Taylor, Dore 2013). At the system level services may still be based on a configuration designed to identify people suitable for interferon based treatment, with conventional pathways containing multiple steps (Arora, Thornton, Murata, Deming, Kalishman, Dion... Qualls 2011). These pathways may be further complicated by required actions by specific practitioners allowing access to services or remuneration for those services. At the practitioner level these restrictions also apply.
Prejudice against PWIDs also operates with many practitioners having the expectation that people will not adhere to medical treatment. Health practitioners may not perceive HCV treatment as a legitimate activity within their practice and may not have the necessary skills and knowledge to be confident in discussing HCV treatment with the client group ( With appropriate training HCV testing can be carried out by a range of personnel, including community pharmacists (The Hepatitis C Trust 2016). Pharmacy provision has particular potential for the OST population as they have daily interactions with pharmacies. However, little is known about whether OST users would find testing at pharmacies acceptable and what other aspects of testing are important to them. To optimise uptake, it is crucial that HCV testing is designed in line with users' preferences (WHO 2016).
In this study, a Discrete Choice Experiment (DCE) was used to elicit the preferences of service users who access OST from pharmacies, to help co-produce the design of an HCV testing service. DCEs are a commonly used stated preference technique for eliciting patient preferences for healthcare services in order to understand what attributes of a service are important and the relative importance of these attributes (Kjaer 2005) .
The design of a service often requires trade-offs between attributes that are important to patients. For example, HCV testing can be provided at a pharmacy but the waiting time to test results may be longer compared to HCV testing by GPs. DCEs can elicit and quantify how patients make trade-offs between these attributes. DCEs are rooted in Lancaster's theory which relates the utility or value of goods and services to the characteristics or attributes of the goods or services. DCEs present individuals with a series of hypothetical choices between different service configurations which vary in a number of characteristics or attributes (for example location of testing, waiting time etc). DCEs are also based on random utility theory (RUT) which means that the choice behaviour of individuals is assumed to be probabilistic rather than deterministic. This means that the utility (or value) of the healthcare service has a systematic component (such as the attributes) that can explain the choices individuals make within the DCE and a random component which include unobserved factors that can explain choices such as psychological factors.
A DCE approach has recently been used to elicit service user preferences for HCV treatment efficacy, the occurrence of adverse treatment effects and the degree of treatment burden (Mühlbacher, Bridges, Bethge and Nubling 2017). However no work has been identified that considers service users' preferences in terms of HCV testing and how they may trade off the different attributes of the testing, such as provider (location), travel distance and waiting time for results. The use of DCEs to predict uptake of treatment for new pathways of care is also a useful feature of this technique when addressing the need to deliver on the ambition to eliminate hepatitis C as a public health concern (Quaife, Terris-Presholt, Di Tanna, Vickerman 2018)
Materials and methods
The aim of this discrete choice experiment was to elicit OST user's preferences for HCV testing, in order to aid the design of a testing service that was acceptable to use from their perspective. The attributes and levels in the DCE were selected following recommended practice (Reed Johnson, Lancsar, Marshall, Kilambi, Mühlbacher, Regier...Bridges 2013). A number of attributes were predetermined by the research question. The aim of the DCE was to examine whether OST users may prefer HCV testing in pharmacy over other settings and provider of testing was therefore a pre-determined attribute. We were also interested in assessing the potential of using financial incentives, therefore financial incentive was also a 
Focus Group Series
In order to test the relevance of these possible attributes to the target group and to explore whether there were any other important attributes, a focus group series was undertaken with service users to establish their views of current services and especially of their experiences of using community pharmacies to access care (Radley, Melville, Easton, Williams and Dillon 2016). Seven focus groups with a total of 41 participants (Table 1) were undertaken during 2015, in a range of settings, aiming to gain a diversity of views and experiences, until no new data (saturation) were achieved. Participants were people prescribed OST by the specialist substance misuse service in Tayside, who provide the majority of care for this group. Participants discussed comparative experiences of partners, family and associates who had undertaken testing and treatment for HCV.
Recruitment to the focus groups concentrated on the following variables:
• Place of Residence -large urban / other urban / accessible small town Sessions were open-ended and ranged from 70-100 minutes. The first focus group served as an internal pilot to test the discussion guide. The seventh focus group with peer mentors was undertaken to provide perspective on the findings from this study. In the local service configuration, peer mentors are experienced service users who have received ORT for a number of years and are further along a recovery pathway: we listened to their reflections and perspectives on the themes that had emerged.
Data from each focus group were digitally recorded and transcribed verbatim, before being coded and analysed by two researchers. Analysis drew on the constant comparison method, which was operationalised within a general thematic approach (Richie and Spencer 1994).
Focus group participants described a range of attributes that had significant overlap with those identified from the literature: stigma, waiting times, confidentiality of results and positive relationships with service providers.
The final attribute list included the pre-determined attributes (who does the testing (provider) and incentive payment) as well as the most important other attributes identified through the literature review and focus groups (whether treated with dignity and respect; travel distance;
and waiting time to test results). The larger the number of attributes, the greater the cognitively complexity of the DCE and therefore the total number of attributes was kept to a manageable level. Plausible levels were assigned to each attribute based on focus group responses and the local context for factors such as laboratory turnaround and travel distance. Table 2 presents the attributes and their levels. Figure 1 shows an example of a discrete choice scenario considered by participants.
Given the number of attributes and their levels, the total number of possible combinations is equal to 512. This was reduced to 16 choice sets using a D-efficient main effects design with flat priors created in SAS (Statistical Analysis Software) (Burges, L and Street D 2005). An opt-out was included in each choice set. The design is presented in Appendix 1.
Design of the Questionnaire
The final study questionnaire contained three sections: Section 1 ascertained participants' preferences on the levels within the 5 attributes; Section 2 presented the 16 discrete choices; Section 3 collected details of patient demography including age, sex, educational level and employment. The cognitive burden of the choice sets in the questionnaire was of especial concern, because of awareness of potential issues with comprehension, literacy levels and attention spans in the respondent group ( A total of 103 participants within six pharmacies in Dundee City that they used to access OST completed the questionnaire. All participants completed a consent form before completing the questionnaire.
Estimation procedure
In each choice set an individual was presented with a choice between three options (j): test A, test B or no test. It assumed that individuals will choose the option that they value most highly, that is, the option they receive the highest utility from. 
Results
The sample characteristics of the respondents completing the discrete choice questionnaire are shown in Table 4 shows the regression results. The results show that individuals prefer to be tested at their own pharmacy. The coefficient on drug worker is not statistically significant indicating that own pharmacy and drug worker are equally preferred. Other pharmacy is the least preferred option. Being treated with dignity and respect, waiting time for test results and travel distance are all important to individuals. The sign of the coefficients is as expected with OST respondents preferring to be treated with dignity and respect, shorter travel distance and shorter waiting times for tests results. Money received is not significant suggesting that the use of financial incentives may not increase uptake of testing. There was statistically significant preference variation for provider (other pharmacy, GP and drug worker) and being treated with dignity and respect. There was no significant preference variation for travel distance or money received. Further analysis (including latent class modelling) suggested that preference heterogeneity was not associated with any of the observed individual characteristics 
Discussion
This study has examined OST users' preferences for hepatitis C testing using a discrete choice experiment, as a method to increase the acceptability of healthcare provision to service users (WHO 2017). It provides supporting evidence of the importance of considering a range of factors when working to improve treatment access (Harris and Rhodes 2013).
The results indicate that individuals prefer to be tested at their own pharmacy or by their drug worker. These two options are preferred to testing by GP or other pharmacy. Being treated with dignity and respect was the most important attribute with waiting time for test results and travel distance also being important to individuals. Being treated with dignity and respect was found to be the most important attribute for test decision making.
In this study, money received did not have a significant effect, suggesting that the use of financial incentives may not increase uptake of testing. However, it may be the case that respondents in our DCE ignored the incentives attribute because payments to produce changes in health behaviour remain controversial; individuals feel shame in accepting money for treatment of their stigmatised condition. Monetary incentives have been found to be helpful in promoting testing for HIV (Rakotonarivo, Schaafsma, Hockley 2016); a recent study has found that financial incentives could be applied to support treatment adherence in HCV care (Wohl, Allmon, Evon, Hurt, Reifeis, Thirumurthy...Mollan 2017). A small pilot study of incentives to promote HCV testing in a prisoner and parole population found little discernible effect from offering incentives (Grebely, Oser, Taylor and Dore 2013). This is in line with our DCE results but further evidence on the effectiveness of incentives in HCV testing is clearly required.
This study adopted accepted best practice in the use of qualitative methods to inform attribute selection (Zaller, Patry, Bazerman, Noska, Kuo, Kurth, Beckwith 2016; Kjaer 2005).
The use of focus groups provided the researchers with a range of perspectives on the experiences of methadone users when using pharmacies as a service. The focus group series identified time as one of the important attributes. The value of time has previously been assessed in patients prescribed OST (Clark, Determann, Petrou, Moro, Bekker-Grob 2014) and is thought to be a good method of measuring relative importance. We used willingness to wait for test results as a 'currency' for expressing the relative importance of the different attributes of HCV testing. Willingness to wait has also been used with this patient group to evaluate treatment attendance (Borisova and Goodman 2003) .
Respondents in the focus group series reacted strongly to the issue of stigma and discrimination. This finding was also identified in the subsequent discrete choice experiment, where a service in which respondents were treated with respect was valued highly. This suggests that getting providers to develop more positive relationships with OST users may be the most effective way to increase uptake of HCV testing.
A number of limitations are noted for this study. Firstly, the DCE choices were hypothetical.
Individuals' real choices (the choices they would make in real life) may not always be the same as the choices they make in a hypothetical DCE. This is referred to as hypothetical bias and is a general limitation of DCEs. However, a recent review suggests that DCEs can make reasonable predictions of health related behaviour (Quaife, Terris-Presholt, Di Tanna, Vickerman 2018). Secondly, the lived experience of stigma was pre-dominant in the focus group discussions and also the most important attribute within the DCE. The strength of this response meant that being treated with dignity and respect was the first concern of participants and may have been a dominant attribute within the DCE. As a result the other attributes may have had little or no impact on decision-making. As it is not possible to 
Conclusion
Provision of simplified, decentralised care for treatment of HCV is one of the key enablers for achieving the WHO target for HCV elimination (WHO 2016). The use of task sharing with non-HCV specialists is also important to increase the service capacity available for care provision. This study demonstrates the acceptability for provision of testing in community pharmacies and evidence that the addition of a pharmacy to the range of providers offering testing can make a contribution to the elimination of Hepatitis C from our communities.
Being treated with dignity and respect was clearly the most important attribute of a testing service and this study provides evidence that uptake of HCV testing can be increased by developing more positive relationships between OST users and providers. 
